Electrocardiographic Pattern in Arrhythmogenic Right Ventricular Cardiomyopathy - 12/08/11
, Luciano Daliento, MD, Ilaria Rigato, MD, Elisa Mazzotti, MD, Antonio Franco Folino, MD, PhD, Martina Perazzolo Marra, MD, Luca Brugnaro, RN, Andrea Nava, MDRésumé |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiac disease characterized by progressive myocardial atrophy and fibrofatty replacement. Standard electrocardiograms (ECGs) and signal-averaged ECGs (SAECGs) were relatively low cost and repeatable diagnostic tools. In this study, ECGs and SAECGs of patients with ARVC were analyzed with the aim to assess the diagnostic capability of these noninvasive techniques. A total of 205 patients with ARVC were analyzed. ECGs were abnormal in 74% of patients and SAECGs were positive in 60%, with normal ECGs mostly related to mild forms of the disease. The most common electrocardiographic abnormalities were localized right QRS prolongation, poor r wave progression in the right precordial leads, incomplete right branch bundle block, prolonged S-wave upstroke in V1 to V3, parietal block, ST-segment elevation in V1 to V3, inversion of T waves beyond V2, and epsilon wave. Low QRS voltages in the precordial leads were frequently present in all patients with ARVC compared with a group of 120 healthy subjects (p = 0.00001). T-wave inversion beyond V3 characterized subjects with severe right ventricular dilatation, whereas in subjects with left ventricular involvement, T-wave inversion in lateral leads was more commonly detected. Overall, the extent of electrocardiographic abnormalities was related to disease extent. In conclusion, abnormalities in ECGs and SAECGs were frequent in patients with ARVC and correlated with disease extent, even if a stereotypical electrocardiographic pattern did not exist. ECGs and SAECGs remain an important tool for the diagnosis and assessment of ARVC extent. Nonetheless, a normal ECG does not exclude the presence of the disease.
Le texte complet de cet article est disponible en PDF.Plan
| This work was supported by Telethon Grant No. GGP05261 from Telethon, Rome, Italy; Ministry of Health, Rome, Italy; Fondazione Cassa di Risparmio, Padova e Rovigo, Italy; and ARVC/D Project QLG1-CT-2000-01091, 5th Framework Programme European Commission, Bruxelles, Belgium. |
Vol 103 - N° 9
P. 1302-1308 - mai 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
